NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) — Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.
Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:
Profire Energy Inc. has agreed to merge with CECO Environmental Corp. for $2.55 per share in cash.
Glycomimetics, Inc. has agreed to a merger with Crescent Biopharma, Inc. At the close of the proposed transaction, Glycomimetics stockholders are anticipated to own approximately 3.1% of the combined company.
Revance Therapeutic Inc. has entered into a definitive agreement with Crown Laboratories for $6.66 per share in cash.
R1 RCM Inc. is set to merge with investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubiller & Rice for $14.30 per share.
Why Your Participation Matters:
SHAREHOLDER CASES: ADDRESSING THE INJUSTICE
As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.
How to Get Involved:
Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact the Firm at moon@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients. Shareholders are advised to act promptly, as legal rights may be time-sensitive. For additional information, please visit Merger Litigation – Kuehn Law.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts:
Moon K. Young
Chief of Operations
Kuehn Law, PLLC
53 Hill Street, Suite 605
Southampton, NY 11968
moon@kuehn.law
(833) 672-0814
Wall St Business News, Latest and Up-to-date Business Stories from Newsmakers of Tomorrow